av/taysha-gene-therapies--big.svg

COM:TAYSHAGTX

Taysha GTx

  • Stock

Last Close

2.06

25/09 14:39

Market Cap

455.12M

Beta: -

Volume Today

213.04K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
997K
-
11.88M
1,091.42%
16.35M
37.68%
8.66M
47.07%
average receivables
book value per share
14.23
-
2.53
82.19%
0.02
99.15%
0.00
97.01%
capex per share
-0.51
-
-0.57
11.35%
-0.57
1.16%
-0.00
99.99%
capex to depreciation
-1.01K
-
-43.81
95.66%
-21.22
51.56%
-2.82
86.70%
capex to operating cash flow
0.30
-
0.18
37.69%
0.28
52.78%
0.05
81.17%
capex to revenue
-9.94
-
-0.25
97.48%
cash per share
14.22
-
3.96
72.16%
2.00
49.51%
0.00
99.94%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.29
-
0.47
60.94%
0.11
76.88%
debt to equity
0.66
-
63.15
9,446.85%
0.25
99.60%
dividend yield
earnings yield
-0.09
-
-0.40
336.16%
-1.71
326.79%
-0.00
99.97%
enterprise value
217.59M
-
352.62M
62.05%
71.38M
79.76%
205.41B
287,671.53%
enterprise value over ebitda
-3.63
-
-2.04
43.84%
-0.57
72.15%
-2.84K
499,637.82%
ev to operating cash flow
-7.08
-
-3.01
57.45%
-0.81
73.20%
-2.81K
348,254.18%
ev to sales
28.53
-
13.29K
46,499.21%
free cash flow per share
-2.25
-
-3.68
63.35%
-2.58
30.00%
-0.00
99.97%
free cash flow yield
-0.08
-
-0.32
272.12%
-1.14
260.85%
-0.00
99.97%
graham net net
13.79
-
0.81
94.12%
-0.85
205.07%
0.00
100.05%
graham number
27.91
-
16.30
41.61%
1.37
91.60%
0.00
99.73%
income quality
0.51
-
0.67
30.97%
0.53
20.61%
0.65
22.92%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-1.54K
-
-121.34
92.10%
-42.77
64.75%
14.49
133.89%
interest debt per share
0.00
-
1.71
108,017.31%
1.45
15.39%
0.00
99.99%
inventory turnover
invested capital
0.66
-
63.15
9,446.85%
0.25
99.60%
market cap
468.85M
-
438.63M
6.45%
99.33M
77.35%
205.54B
206,818.16%
net current asset value
-135K
-
243.67M
180,599.26%
41.03M
83.16%
-28.91M
170.46%
52.07M
280.12%
net debt to ebitda
4.19
-
0.50
88.14%
0.22
55.28%
1.73
676.51%
net income per share
-2.43
-
-4.66
91.45%
-3.86
17.21%
-0.00
99.98%
operating cash flow per share
-1.74
-
-3.11
78.71%
-2.01
35.31%
-0.00
99.97%
payables turnover
receivables turnover
research and ddevelopement to revenue
36.44
-
3.67
89.92%
return on tangible assets
-0.17
-
-0.82
393.72%
-1.34
63.76%
-0.65
51.90%
revenue per share
0.06
-
0.00
99.77%
roe
-0.17
-
-1.84
975.06%
-178.69
9,614.18%
-1.49
99.17%
roic
-0.12
-
-0.94
670.56%
-2.04
115.99%
-0.64
68.54%
sales general and administrative to revenue
14.93
-
1.94
86.98%
shareholders equity per share
14.23
-
2.53
82.19%
0.02
99.15%
0.00
97.01%
stock based compensation to revenue
7.21
-
0.51
92.91%
tangible asset value
-135K
-
251.30M
186,249.63%
95.38M
62.04%
949K
99.01%
74.94M
7,796.42%
tangible book value per share
14.23
-
2.53
82.19%
0.02
99.15%
0.00
97.01%
working capital
-135K
-
244.12M
180,932.59%
107.86M
55.82%
33.63M
68.82%
113.11M
236.37%

All numbers in (except ratios and percentages)